Jacobs Levy Equity Management’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-859,373
| Closed | -$1.58M | – | 1196 |
|
|
2024
Q4 | $1.58M | Buy |
859,373
+37,627
| +5% | +$69.2K | 0.01% | 648 |
|
|
2024
Q3 | $2.84M | Sell |
821,746
-228,443
| -22% | -$790K | 0.01% | 535 |
|
|
2024
Q2 | $3.08M | Sell |
1,050,189
-19,333
| -2% | -$56.6K | 0.01% | 530 |
|
|
2024
Q1 | $6.04M | Buy |
1,069,522
+729,239
| +214% | +$4.12M | 0.03% | 389 |
|
|
2023
Q4 | $1.46M | Sell |
340,283
-85,408
| -20% | -$366K | 0.01% | 657 |
|
|
2023
Q3 | $1.48M | Sell |
425,691
-145,702
| -25% | -$506K | 0.01% | 611 |
|
|
2023
Q2 | $2.66M | Sell |
571,393
-93,208
| -14% | -$433K | 0.02% | 524 |
|
|
2023
Q1 | $3.07M | Sell |
664,601
-2,875
| -0.4% | -$13.3K | 0.02% | 488 |
|
|
2022
Q4 | $5.39M | Sell |
667,476
-75,752
| -10% | -$612K | 0.04% | 379 |
|
|
2022
Q3 | $4.13M | Sell |
743,228
-273,806
| -27% | -$1.52M | 0.03% | 429 |
|
|
2022
Q2 | $5.3M | Buy |
1,017,034
+396,554
| +64% | +$2.07M | 0.04% | 409 |
|
|
2022
Q1 | $5.1M | Buy |
+620,480
| New | +$5.1M | 0.03% | 415 |
|
|
2021
Q2 | – | Sell |
-106,581
| Closed | -$2.43M | – | 1113 |
|
|
2021
Q1 | $2.43M | Sell |
106,581
-50,720
| -32% | -$1.15M | 0.02% | 557 |
|
|
2020
Q4 | $3.42M | Buy |
157,301
+104,288
| +197% | +$2.26M | 0.03% | 468 |
|
|
2020
Q3 | $533K | Sell |
53,013
-9,714
| -15% | -$97.7K | 0.01% | 780 |
|
|
2020
Q2 | $487K | Sell |
62,727
-2,804
| -4% | -$21.8K | 0.01% | 793 |
|
|
2020
Q1 | $668K | Buy |
65,531
+197
| +0.3% | +$2.01K | 0.01% | 707 |
|
|
2019
Q4 | $719K | Buy |
65,334
+34,548
| +112% | +$380K | 0.01% | 736 |
|
|
2019
Q3 | $280K | Sell |
30,786
-12,581
| -29% | -$114K | ﹤0.01% | 792 |
|
|
2019
Q2 | $494K | Sell |
43,367
-159
| -0.4% | -$1.81K | 0.01% | 741 |
|
|
2019
Q1 | $496K | Buy |
+43,526
| New | +$496K | 0.01% | 775 |
|